St. Jude Says Cancer Drug Research Infringes Patents

Law360, Los Angeles (October 15, 2013, 8:09 PM EDT) -- St. Jude Children’s Research Hospital Inc. sued Xcovery Holding Co. LLC in Tennessee federal court on Tuesday, accusing Xcovery of infringing three of St. Jude’s patents during its research and development of X-396, a drug being developed for treatment of advanced cancers.

The lawsuit raises allegations that Xcovery has conducted various infringing activities in its efforts to create and evaluate small molecule tyrosine kinase inhibitors, including but not limited to X-396. Since at least June 15, 2012, Xcovery has been conducting a Phase 1 Study of...
To view the full article, register now.